Schizophrenia: all 3,539 studies

Page 30 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.

• Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia PatientsCompletedNCT00780884Not applicable
• An Observational Study to Assess Treatment & Outcomes Data in Patients Receiving Long-Acting Injectable RisperidoneCompletedNCT00774085
• Efficacy of Lu 31-130 in Patients With SchizophreniaCompletedNCT00770744Phase 2
• Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Smokers With and Without SchizophreniaCompletedNCT00770237Not applicable
• Study Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of SchizophreniaWithdrawnNCT00768612Phase 2
• Efficacy of Lu 31-130 in Patients With SchizophreniaCompletedNCT00768326Phase 2
• Safety Study of an Antipsychotic, Sertindole, to Treat SchizophreniaCompletedNCT00763438Phase 4
• Efficacy Study on Cognitive Functions in Schizophrenic PatientsCompletedNCT00761670Phase 4
• Study on Metabolic Parameters of Sertindole in Patients With SchizophreniaCompletedNCT00759460Phase 3
• Exploratory Cognition Study of Sertindole in Patients With SchizophreniaCompletedNCT00759421Phase 3
• Observation of Change in Clinical Global Impression Scores in Schizophrenia Patients Receiving Seroquel XR TreatmentCompletedNCT00758251
• Study Evaluating and Comparing Single Dose and Multiple Dose Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese and Caucasian Adults.CompletedNCT00758030Phase 1
• Memantine as Adjunctive Therapy for Schizophrenia Negative SymptomsCompletedNCT00757978Phase 4
• Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset SchizophreniaTerminatedNCT00757497Phase 1
• Treat Clozapine ( CLZ )-Resistant Schizophrenia Comparing CLZ + Haloperidol vs. CLZ + Electroconvulsive Therapy (ECT)CompletedNCT00753051Not applicable
• 24-Week Open Label Extension to a Randomized, 6-Week Double Blind, Placebo Controlled Study, to Evaluate the Safety and Tolerability of Flexible Doses of Extended Release OROS® Paliperidone in the Treatment of Geriatric Subjects With SchizophreniaCompletedNCT00752427Phase 3
• Non-interventional Study -Observe Treatment Efficacy in Maintaining Symptoms Control in Schizophrenia With Seroquel XRCompletedNCT00750087
• Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With SchizophreniaCompletedNCT00749970
• A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With SchizophreniaWithdrawnNCT00743847Phase 2
• Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With HaloperidolCompletedNCT00740259Phase 4
• A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine DependenceStatus unknownNCT00737256Phase 2
• rTMS Effects on Smoking Cessation and Cognition in SchizophreniaCompletedNCT00736710Not applicable
• Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic SubjectsTerminatedNCT00734435Phase 2
• Minocycline for the Treatment of Early-Phase SchizophreniaCompletedNCT00733057Phase 3
• An Efficacy and Safety Study of 3 Fixed Doses of JNJ-37822681 in Participants With SchizophreniaCompletedNCT00728195Phase 2
• Varenicline Treatment in Alcohol and Nicotine Dependent Patients With SchizophreniaCompletedNCT00727103Phase 4
• A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia PatientsStatus unknownNCT00725855Phase 2
• Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020CompletedNCT00722176Phase 2
• Association of Multiple Genetic Polymorphisms With Clozapine-Associated Metabolic Change in SchizophreniaStatus unknownNCT00717509
• Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.CompletedNCT00716755Not applicable
• Anticholinergic Burden in SchizophreniaTerminatedNCT00715377Not applicable
• Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental IllnessCompletedNCT00714818Phase 3
• Impact of Genetic Counseling for Individuals With Mental IllnessCompletedNCT00713804Phase 3
• Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute SchizophreniaCompletedNCT00712686Phase 3
• Study With Information Technology (IT) - Aided Preventive Program in SchizophreniaCompletedNCT00712660Not applicable
• Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label StudyStatus unknownNCT00708396Phase 4
• Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug TreatmentCompletedNCT00707382Not applicable
• Efficacy of Bifeprunox in Patients With SchizophreniaTerminatedNCT00704509Phase 3
• Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)WithdrawnNCT00702793Phase 4
• A Pharmacogenetic Investigation of Antipsychotics in Schizophrenia and Schizophrenia-Like PsychosesTerminatedNCT00701753
• Linear and Non-linear Analysis of EEG Changes in Schizophrenia After Atypical Antipsychotics MedicationStatus unknownNCT00698295
• INVISION - An Observational Study to Explore Effectiveness, Tolerability and Safety of Paliperidone ER in Patients With SchizophreniaCompletedNCT00697658
• Observational Study to Assess Outcomes During Antipsychotic Treatment With Paliperidone ER or Other Oral AntipsychoticsCompletedNCT00696813
• Training-induced Cerebral Reorganization in SchizophreniaCompletedNCT00695708Not applicable
• Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset SchizophreniaCompletedNCT00694889Phase 1/2
• Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic TreatmentCompletedNCT00692133
• Safety and Efficacy of Switching to Quetiapine in Outpatients With SchizophreniaCompletedNCT00690365
• Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy SubjectsCompletedNCT00690170Phase 1
• Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical AntipsychoticsCompletedNCT00689325
• A German Multicenter Study on Toxoplasma Gondii in First-episode SchizophreniaStatus unknownNCT00686400
• A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode SchizophreniaCompletedNCT00686140Not applicable
• Knowledge and Perception of Smoking Risks/ConsequencesCompletedNCT00686101
• Tolerability, Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation in Subjects With Negative Symptoms and Cognitive Deficits of SchizophreniaStatus unknownNCT00685321Not applicable
• FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study SurveyCompletedNCT00683891
• Cardio Risk of Acute Schizophrenia Olanzapine DukeWithdrawnNCT00672464Phase 4
• Extract of Ginkgo Biloba and Tardive DyskinesiaCompletedNCT00672373Phase 3
• A 52 Week Open-label Extension Trial Following the Double-blind Efficacy and Safety Study R076477-SCH-305.CompletedNCT00668837Phase 3
• Bipolar and Schizophrenia Consortium for Parsing Intermediate PhenotypesCompletedNCT00666432
• Familial Schizophrenia and Spectrum Personality DisordersCompletedNCT00666146
• Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation SchizophreniaStatus unknownNCT00664274Not applicable
• Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental IllnessCompletedNCT00661869Not applicable
• Treatment of Neuroleptic Induced Acute Akathisia With TrazodoneCompletedNCT00659919Phase 4
• Efficacy of Bifeprunox in Patients With SchizophreniaTerminatedNCT00658645Phase 3
• Acceptance and Commitment Therapy for DelusionsCompletedNCT00657631Not applicable
• Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for PsychosisCompletedNCT00655239Not applicable
• Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With SchizophreniaCompletedNCT00654706Phase 3
• Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With SchizophreniaCompletedNCT00654576Phase 4
• A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic PatientsCompletedNCT00653406Phase 1/2
• A 52-week, Open-label Extension Study Following a 6-week, Double-blind, Placebo- and Active- Controlled Study (R076477-SCH-303) to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With SchizophreniaCompletedNCT00650793Phase 3
• A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic DisordersCompletedNCT00650611Phase 2
• A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective DisorderCompletedNCT00650429Phase 4
• A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic DrugsCompletedNCT00649844Phase 3
• A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic DrugsCompletedNCT00649064Phase 4
• Cognitive Determinants of Psychoeducation and Information in PsychosesStatus unknownNCT00646256Not applicable
• Genetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive FunctionStatus unknownNCT00645580Not applicable
• A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic SchizophreniaTerminatedNCT00645515Phase 3
• Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.CompletedNCT00645502Phase 1
• A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese PatientsCompletedNCT00645372Phase 3
• A 52 Week Open Label Extension Trial Following the Recurrence Prevention Study R076477-SCH-301 to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia.CompletedNCT00645307Phase 3
• A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective DisorderTerminatedNCT00645229Phase 3
• Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable RisperidoneCompletedNCT00644852
• A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of PsychosisCompletedNCT00644800Phase 4
• Efficacy and Safety of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With SchizophreniaCompletedNCT00639483Phase 2
• Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute SchizophreniaCompletedNCT00637234Phase 2/3
• Ethyl-EPA Treatment of Prodromal PatientsCompletedNCT00634361Phase 2/3
• A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized PatientsCompletedNCT00634348Phase 4
• Multicenter, Open-Label, Randomised, Haloperidol-controlled Study to Evaluate Seroquel as Mono-Therapy in the Treatment of Agitated Symptoms in the Patients With Acute Episode of SchizophreniaCompletedNCT00631722Not applicable
• The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic PatientsTerminatedNCT00629252Not applicable
• Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and PharmacokineticsCompletedNCT00628420Phase 1
• Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic PsychosisCompletedNCT00628290Phase 2
• Efficacy of Docosahexaenoic Acid on Tardive DyskinesiaWithdrawnNCT00621634Phase 2
• Study Evaluating Multiple Ascending Dose in Schizophrenia PatientsTerminatedNCT00620568Phase 1
• Genetics of SchizophreniaStatus unknownNCT00619437
• Social Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical TrailCompletedNCT00618280Phase 1/2
• Schizophrenic Patients Taking Part in Integrated Care ProgramTerminatedNCT00617214
• A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.CompletedNCT00616798Phase 2
• Efficacy of Pregnenolone in Patients With SchizophreniaCompletedNCT00615511Phase 2
• The Effect of Plasma Osmolality on Brain GlutamateCompletedNCT00611741Phase 1
• Add-on Simvastatin in Schizophrenia TrialTerminatedNCT00605995Not applicable
• Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With SchizophreniaStatus unknownNCT00604760Phase 2

← Schizophrenia overview